SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899243-03-000584
Filing Date
2003-03-21
Accepted
2003-03-21 17:29:08
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR ENDED 12/31/2002 d10k.txt 10-K 428118
3 AMENDED AND RESTATED BY LAWS OF THE COMPANY dex32.txt EX-3.2 51328
4 FIRST AMENDMENT TO CERTAIN OPERATIVE AGREEMENTS dex1016.txt EX-10.16 46129
5 FIRST AMENDMENT TO CREDIT AGREEMENT dex1017.txt EX-10.17 22174
6 SUBSIDIARIES OF THE REGISTRANT dex21.txt EX-21 2616
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.txt EX-23.1 601
8 CERTIFICATION OF CEO dex991.txt EX-99.1 1083
9 CERTIFICATION OF CFO dex992.txt EX-99.2 1100
  Complete submission text file 0000899243-03-000584.txt   555601
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 03612905
SIC: 8093 Services-Specialty Outpatient Facilities, NEC